Vergenix™FG IS A RECOMBINANT HUMAN COLLAGEN
MATRIX FOR THE MANAGEMENT OF CHRONIC AND ACUTE WOUNDS
Produced via bioengineered
Identical to type I collagen
produced by the human body
3D scaffold for deep/
irregular wound shapes
A single application
“Vegrenix™FG is the most effective filler I used so far.
It is easy to use, and in my surgical practice helps me
in addressing problems with loss of substance after
debridement or bone and joint removal for osteomyelitis.
In two words: IT WORKS”
Prof. Alberto Piaggesi
Director, Diabetic Foot Section, University of Pisa,
Member of Board of Directors of Diabetic Foot Study
Group of European Association. Honorary Secretary – EWMA
LATEST NEWS & EVENTS
New Vergenix™FG clinical results now published
Study by Iacopi E et al from the University Hospital in Pisa, Italy shows increased healing rate and shortened healing time in patients with post-surgical diabetic foot wounds treated with Vergenix™ FG.
Vergenix™FG now available in Ukraine
Patients in Ukraine will now have access to Vergenix™FG.
For more details, contact us
Prof. Nikolaos Tentolouris from Laikο General Hospital of Athens, Greece, will present a poster titled “Recombinant human collagen-based flowable matrix for chronic wound management: a case study series”.